Medicine and Dentistry
Patient
100%
Glioblastoma
88%
Neoplasm
87%
Surgery
66%
Cells
58%
Therapeutic Procedure
41%
Chordoma
33%
Overall Survival
25%
Tumor Cell
25%
Epidermal Growth Factor Receptor
23%
Analysis
22%
Ganglioglioma
22%
Progression Free Survival
21%
Magnetic Resonance Imaging
21%
Brain
20%
Age
19%
Combination Therapy
19%
Facial Nerve
19%
Temozolomide
18%
Radiation Therapy
18%
Craniopharyngioma
18%
Survival
17%
Methylation
16%
Radiation
16%
Follow up
16%
Complication
16%
Recurrent Disease
15%
Xenograft
15%
Adjuvant Radiotherapy
14%
Vasculotropin
14%
Diagnosis
13%
Endoscope
13%
Malignant Neoplasm
13%
Rapamycin
12%
Differentiation
12%
Mesenchymal Stem Cell
12%
Blood Brain Barrier
11%
Ependymoma
11%
Skull Surgery
11%
Phosphodiesterase V
11%
Growth
11%
Neural Stem Cell
11%
Chemotherapy
10%
Microvessel
10%
Inpatient
10%
Brain Tumor
10%
Bevacizumab
10%
Messenger RNA
10%
Adult
10%
Systematic Review
10%
Biochemistry, Genetics and Molecular Biology
Stem Cell
24%
Methylation
22%
Angiogenesis
21%
Growth
19%
Nuclear Magnetic Resonance Spectroscopy
17%
Progression Free Survival
16%
Electric Potential
16%
Overall Survival
16%
Vascular Endothelial Growth Factor
14%
Survival
12%
Phenotype
12%
Epidermal Growth Factor Receptor
11%
Proteomics
11%
Radiation
11%
Promoter Region
10%
Messenger RNA
9%
Vascular Endothelial Growth Factor
8%
Signal Transduction
8%
Reduction (Chemistry)
8%
Bevacizumab
7%
Density
7%
Sample
6%
Gene Expression Profiling
6%
Nested Gene
6%
Ribonucleoprotein
5%
Monocyte
5%
Regorafenib
5%
Oncogene C Myc
5%
Photon
5%
MEG3
5%
Lipid
5%
MicroRNA
5%
Long Non-Coding RNA
5%
SMAD
5%
Decompression
5%
Bevacizumab
5%
Cell Migration
5%
Aptitude
5%
Cell Growth
5%
Mutation
5%
Blood Level
5%
Modulation
5%
Radiosensitivity
5%
Mesenchymal-Epithelial Transition
5%
Antiangiogenic Activity
5%
Neoangiogenesis
5%
Neuroscience
Chordoma
28%
Methylation
22%
Glioma
20%
Bevacizumab
16%
Glioblastoma Multiforme
15%
Temozolomide
15%
Brain
13%
Ependymoma
11%
Phosphodiesterase V
11%
Promoter Region
11%
Cell Line
10%
Chemotherapy
9%
In Vivo
8%
Meningioma
8%
Protein
8%
Magnetic Resonance Imaging
7%
Blood Brain Barrier
7%
Phosphatase
6%
Phenotype
6%
Osteogenic Protein 1
6%
Hydrocephalus
5%
Pituitary Surgery
5%
Aminolevulinic Acid
5%
Monocyte
5%
Cavernous Sinus
5%
Craniopharyngioma
5%
Ribonucleoprotein
5%
SOX2
5%
Peripheral Nerve Injury
5%
Prolactinoma
5%
Oncogene C Myc
5%
Regorafenib
5%
Ulnar Nerve
5%
Spinal Cord
5%
Motor Evoked Potential
5%
Somatostatin Derivative
5%
Trigeminal Neuralgia
5%
In Vitro
5%
Brain Tumor
5%
